ESAP 2016

OVERVIEW

The Endocrine Self-Assessment Program (ESAP™) is a self-study curriculum aimed at physicians seeking initial certification or recertification in endocrinology, program directors interested in a testing and training instrument, and clinicians simply wanting a self-assessment and a broad review of endocrinology. ESAP 2016 is available in both print and online formats. It consists of 120 brand-new multiple-choice questions in all areas of endocrinology, diabetes, and metabolism. There is extensive discussion of each correct answer and references. ESAP is updated annually with new questions. For accessibility for international practitioners, SI units are included.

CLICK HERE TO PURCHASE ESAP AT THE SOCIETY ONLINE STORE

 

Target Audience

Target audience: 

ESAP is a self-study curriculum aimed at physicians seeking initial certification or recertification in endocrinology, program directors interested in a testing and training instrument, and clinicians simply wanting a self-assessment and a broad review of endocrinology

Learning Objectives

Learning objectives: 

Upon completion of this educational activity, participants will be able to:

  • Recognize clinical manifestations of endocrine and metabolic disorders and select among current options for diagnosis, management, and therapy.
  • Identify risk factors for endocrine and metabolic disorders and develop strategies for prevention.
  • Evaluate endocrine and metabolic manifestations of systemic disorders.
  • Use existing resources pertaining to clinical guidelines and treatment recommendations for endocrine and related metabolic disorders to guide diagnosis and treatment.

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Medical Knowledge
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
Quality Improvement and Healthcare Delivery
General Endocrinology
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Nutrition
Obesity
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Available credit: 
  • 40.00 AMA PRA Category 1 Credits
  • 14.00 RCP MOC
  • 40.00 ABIM MOC
  • 40.00 CME Certificate of Participation
Course opens: 
03/01/2016
Course expires: 
04/04/2019
Cost:
$350.00
Pricing: 
Member
250
Non-Member
350
In-Training/Early Career Member
199
Rating: 
Average: 4.5 (11 votes)
4.454545

Alan C. Dalkin, MD, Program Chair
Professor of Medicine
Division of Endocrinology and Metabolism
University of Virginia

Shehzad S. Basaria, MD
Associate Professor of Medicine
Medical Director, Section on Men’s Health, Aging, and Metabolism
Brigham and Women’s Hospital
Harvard Medical School

Kristien Boelaert, MD
Reader in Endocrinology
Center for Endocrinology, Diabetes, and Metabolism
University of Birmingham

Maria L. Collazo-Clavell, MD
Associate Professor of Medicine
Mayo Clinic College of Medicine

Kathryn McCrystal Dahir, MD
Assistant Professor of Medicine
Division of Endocrinology
Vanderbilt University Medical Center

Thomas W. Donner, MD
Associate Professor of Medicine
Division of Endocrinology, Diabetes, and Metabolism
Johns Hopkins University

James W. Findling, MD
Professor of Medicine
Medical College of Wisconsin

Pamela U. Freda, MD
Professor of Medicine at CUMC
Columbia University, College of Physicians and Surgeons

Marie Freel, MB, ChB, PhD
Consultant Endocrinologist
Queen Elizabeth University Hospital
Glasgow, United Kingdom

Jennifer Green, MD
Associate Professor of Medicine
Division of Endocrinology, Metabolism, and Nutrition
Duke University Medical Center

Shubhada Jagasia, MD, MMHC
Professor of Medicine
Vice Chair for Clinical Affairs
Department of Medicine
Vanderbilt University Medical Center

Jacqueline Jonklaas, MD, PhD
Associate Professor
Division of Endocrinology and Metabolism
Georgetown University

Lisa R. Tannock, MD
Professor of Medicine
Chief, Division of Endocrinology and Molecular Medicine
University of Kentucky and Department of Veterans Affairs

Nicholas A. Tritos, MD, DSc
Associate Professor of Medicine
Harvard Medical School
Neuroendocrine and Pituitary Clinical Center
Massachusetts General Hospital

Adrian V. Vella, MD
Professor of Medicine
Mayo Clinic College of Medicine

Corrine Welt, MD
Professor of Medicine
University of Utah School of Medicine

Abbie L. Young, MS, CGC, ELS(D)
Medical Editor

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s ESAP Faculty Working Group.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/ partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity: Shehzad S. Basaria, MD, is a consultant for Eli Lilly. Kathryn McCrystal Dahir, MD, is on the advisory board for Alexion. Thomas W. Donner, MD, is a study site principle investigator for Novo Nordisk. James W. Findling, MD, is an investigator/consultant for Corcept Therapeutics and Novartis. Pamela U. Freda, MD, is an investigator for Novo Nordisk, Pfizer, and Novartis; serves on the advisory board for Pfizer, IPSEN, and Novo Nordisk, and is a content reviewer for UpToDate. Duke University receives funds from Merck, AstraZeneca, Janssen, and GlaxoSmithKline for research performed by Jennifer Green, MD. These funds support a portion of her salary. Dr. Green has also received honoraria from Merck and Boehringer Ingelheim for serving as a consultant, honoraria from BioScientifica for editorial activities. Nicholas Tritos, MD, DSc, receives research support from IPSEN, US, Pfizer, Inc., Novo Nordisk, and Norvartis. Dr. Tritos also receives consultant fees from Pfizer, Inc. and his spouse is an employee of Pfizer, Inc. Adrian V. Vella, MD, is a consultant for sanofi-aventis and Genentech and receives grant support from Novartis and BioKier. Corrine Welt, MD, is a writer for UpToDate and a consultant for Astra Zeneca and Takeda.

The following faculty reported no relevant financial relationships: Kristien Boelaert, MD; Maria L. Collazo-Clavell, MD; Alan C. Dalkin, MD; Marie Freel, MB, ChB, PhD; Shubhada Jagasia, MD, MMHC; Jacqueline Jonklaas, MD, PhD; and Lisa R. Tannock, MD.

The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

USE OF PROFESSIONAL JUDGMENT
The educational content in this self-assessment test relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE
The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity has not received commercial support.

Accreditation Statement 

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring material for a maximum of 40.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 40 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Available Credit

  • 40.00 AMA PRA Category 1 Credits
  • 14.00 RCP MOC
  • 40.00 ABIM MOC
  • 40.00 CME Certificate of Participation

Accreditation Period

Course opens: 
03/01/2016
Course expires: 
04/04/2019

Price

Cost:
$350.00

Required Hardware/software

Required hardware / software: 

To complete this activity, participants must have access to a computer or mobile device with an Internet connection and use a major Web browser, such as Internet Explorer 10+, Firefox 32+, Safari, or Google Chrome 37+. In addition, cookies and Javascript must be enabled in the browser’s options.